Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 February 2005, Vol. 105, No. 4, pp. 1606-1613.
Prepublished online as a Blood First Edition Paper on October 26, 2004; DOI 10.1182/blood-2004-06-2406.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-06-2406v1
105/4/1606    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, A.
Right arrow Articles by Klein, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, A.
Right arrow Articles by Klein, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted June 24, 2004
Accepted October 12, 2004

PSK and Trx80 inhibit B cell growth in EBV infected cord blood mononuclear cells through T cells activated by the monocyte products IL15 and IL12

Anquan Liu*, Jack L Arbiser, Arne Holmgren, George Klein, and Eva Klein

Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden
Department of Dermatology, Emory University School of Medicine, Atlanta, GA, USA
Medical Nobel Institute for Biochemistry, Department of Biophysics and Biochemistry, Karolinska Institute, Stockholm, Sweden

* Corresponding author; email: Anquan.Liu{at}mtc.ki.se.

EBV specific immunological memory is not transferred from mother to child. In vitro infection of cord blood cells can therefore readily lead to the outgrowth of transformed B lymphocytes. We found that the immunomodulator PSK or the mitogenic cytokine Trx80 inhibited the EBV induced B cell proliferation. Using SAP induction as a sign for T, NK cell activation we could follow it without any need for cell separation because neither macrophages nor B lymphocytes express SAP. The results suggest the following scenario: EBV infected and activated B lymphocytes. They were recognized by T cells that became posed for responding to cytokines produced by monocytes. PSK and Trx80, which is a secreted C-terminally truncated thioredoxin, both activated the monocytes which then produced cytokines in the presence of the primed T cells. PSK induced IL-15 while Trx80 induced IL-12 production. Both cytokines activated the T cells for function. PI 3-kinase and ROS were involved in the PSK induced activation of monocytes. Restimulation of the cultures with EBV transformed B cells generated specific cytotoxic activity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
A. Liu, H.-E. Claesson, Y. Mahshid, G. Klein, and E. Klein
Leukotriene B4 activates T cells that inhibit B-cell proliferation in EBV-infected cord blood-derived mononuclear cell cultures
Blood, March 1, 2008; 111(5): 2693 - 2703.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020